[Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients].
We studied 19 in patients with serious pulmonary or genito-urinary infections related to cancer of various origin. The patients were treated with amikacin (7.5 mg/kg/day) and clindamycin. The clinical response was found "satisfactory" in 16 of the treated group; the bacteriological response was "good" in 12 and "nearly good" in 4 of treated patients. We found no side-effects.
Citerio
P
P
Regione Lombardia, U.S.L. 58, Melzo.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000583:Amikacin / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D005832:Genital Diseases, Male / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000209:etiology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000209:etiology
D000583:Amikacin
Amikacina nel trattamento delle infezioni genito-urinarie e polmonari nel paziente oncologico.